Transparency Directive

19 Dec 2006 16:52

Alliance Pharma PLC19 December 2006 For immediate release 19 December 2006 Alliance Pharma plc(the 'Company') Voting Rights and Capital In conformity with the Transparency Directive's transitional provision 6 wewould like to notify the market of the following: The Company's capital consists of 162,061,773 ordinary shares of 1p each withvoting rights. The Company holds no ordinary shares in Treasury. Therefore, the total number of voting rights in Alliance Pharma plc is162,061,773 The above figure may be used by shareholders as the denominator for thecalculations by which they will determine if they are required to notify theirinterest in, or a change to their interest in, Alliance Pharma plc under theFSA's Disclosure and Transparency Rules. For further information: Alliance Pharma plc + 44 (0) 1249 466966 John Dawson, Chief ExecutiveMaddy Scott, Finance Directorwww.alliancepharma.co.uk Buchanan Communications + 44 (0) 20 7466 5000 Lisa Baderoon This information is provided by RNS The company news service from the London Stock Exchange